Loading organizations...
§ Private Profile · Boston, MA, USA
AI medical software company developing FDA-cleared imaging analysis for cardiovascular diagnostics, characterizing coronary plaques.
Based in Boston, United States, Elucid develops artificial intelligence-powered imaging analysis software designed for advanced cardiovascular diagnostics. The company's flagship medical product, PlaqueIQ, operates as an FDA-cleared computed tomography angiography algorithm that quantifies and characterizes coronary plaques using ground truth histology validation to assist physicians in treating cardiovascular disease. In the fourth quarter of 2023, the enterprise secured $80 million in Series C venture capital funding led by Elevage Medical Technologies to support the commercialization of its diagnostic software. To drive global expansion and scale operations from its newly established corporate headquarters, the firm appointed Kelly Huang as chief executive officer in July 2024, joining executive chairman Scott Huennekens on the leadership team. The medical technology company was co-founded by Dr. Samuel Knauss, though its exact founding year currently remains undisclosed in public records.
Elucid has raised $115.0M across 3 funding rounds.
Elucid has raised $115.0M in total across 3 funding rounds.
Elucid has raised $115.0M in total across 3 funding rounds.
Elucid's investors include Kelly Huang, Romeen Sheth, Sahil Bloom, Shaan Puri, Biovision Ventures, BlueStone Venture Partners, Bold Brain Ventures, IAG Capital Partners, John Fichthorn, Orrin Ailloni-Charas, Ashok Gowda, Angel Physicians Fund.
Elucid has raised $115.0M across 3 funding rounds. Most recently, it raised $80.0M Series C in November 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Nov 9, 2023 | $80M Series C | Kelly Huang | Romeen Sheth, Sahil Bloom, Shaan Puri | Announced |
| Jun 23, 2022 | $27M Series B | — | Biovision Ventures, BlueStone Venture Partners, Bold Brain Ventures, IAG Capital Partners, John Fichthorn | Announced |
| May 10, 2021 | $8M Series A | Orrin Ailloni Charas, Ashok Gowda | Angel Physicians Fund, BlueStone Venture Partners, Checkmate Capital Group, IAG Capital Partners, University OF Michigan, Willamette Valley Capital | Announced |